Karl E. Wende, PhD

Research Assistant Professor, Department of Epidemiology and Environmental Health

Contact Information

633 Kimball Tower
Buffalo, NY 14214
Phone: 716-829-6954
Fax: 716-829-6040
Email: kwende@buffalo.edu

View map

Faculty Links

Research Interests: occupational health, tobacco control, and data registry administration

Selected Publications

  • Goodkin D, Priore R, Wende K, Campion M, Bourdette D, Herndon R, Fischer J, Jacobs L, Cookfair D, Rudick R, Richert J, Salazar A, Granger C, Simon J, Alam J, Bartoszak D, Braiman J, Brownscheidle C, Coats M, Cohan S, Dougherty D, Kinkel R, Mass M, Munschauer F, Pullicino P, Scherokman B, Weinstock-Guttman B, Whitham R. Comparing the ability of various composite outcomes to discriminate treatment effects in MS clinical trials. The Multiple Sclerosis Collaborative Research Group (MSCRG). Multiple Sclerosis. 1998; 4(6):480-486.
  • Wende K. The future looks bright. Rehab Management. 1999; 12(2):32-4.
  • Simon JH, Jacobs LD, Campion MK, Rudick RA, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Simonian N, Lajaunie M, Miller DE, Wende KE, Martens Davidson A, Kinkel RP, Munschauer FE, Brownscheidle CM, Multiple Sclerosis Collaborative Research Group (MSCRG). A longitudinal study of brain atrophy in relapsing multiple sclerosis. Neurology. 1999; 53(1):139-148.
  • Jacobs L, Wende K, Brownscheidle C, Apatoff B, Coyle P, Goodman A, Gottesman M, Granger C, Greenberg S, Herbert J, Krupp L, Lava N, Mihai C, Miller A, Perel A, Smith C, Snyder D, New York State Multiple Sclerosis Consortium. A profile of multiple sclerosis: The New York State Multiple Sclerosis Consortium. Multiple Sclerosis. 1999; 5(5):369-76.
  • Rudick RA, Cookfair DL, Simonian NA, Ransohoff RM, Richert JR, Jacobs LD, Herndon RM, Salazar AM, Fischer JS, Granger CV, Goodkin DE, Simon JH, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munchsauer FE, O'Reilly K, Priore RL, Pullicino P, Scherokman B, Wende K, Weinstock-Guttman B, Whitham R. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. Journal of Neuroimmunology. 1999; 93 (1-2): 8-14.
  • Simon JH, Lull J, Jacobs LD, Rudick RA, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Sheeder J, Miller D, McCabe K, Serra A, Campion MK, Fischer JS, Goodkin DE, Simonian N, Lajaunie M, Wende K, Martens-Davidson A, Kinkel RP, Munschauer FE 3rd, A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research Group. Neurology. 2000; 55(2):185-92.
  • Schwid SR, Goodman AD, Apatoff BR, Coyle PK, Jacobs LD, Krupp LB, Miller AE, Wende KE, Brownscheidle CM, New York State Multiple Sclerosis Consortium. Are quantitative functional measures more sensitive to worsening MS than traditional measures? Neurology. 2000; 55(12):1901-3.
  • Fischer JS, Priore RL, Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Goodkin DE, Granger CV, Simon JH, Grafman JH, Lezak MD, O'Reilly Hovey KM, Perkins KK, Barilla-Clark D, Schacter M, Shucard DW, Davidson AL, Wende KE, Bourdette DN, Kooijmans- Coutinho MF. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol. 2000; 48(6):885-92.
  • Stewart CC, Cookfair DL, Hovey KM, Wende KE, Bell DS, Warner CL. Predictive immunophenotypes: Disease-related profile in chronic fatigue syndrome. Cytometry. 2003; 53B(1):26-33.
  • Granger CV, Wende KE, Brownscheidle CM, Use of the FIM™ Instrument in a Trial of Intramuscular Interferon β-1a for Disease Progression in Relapsing-Remitting Multiple Sclerosis. Am J Phys Med Rehabil. 2003; Vol. 82, No. 6.

revised: 2008.02.04